SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals
SEC Accession No. 0001193125-11-352289
Filing Date
2011-12-27
Accepted
2011-12-27 09:10:23
Documents
1
Filing Date Changed
2011-12-27
Group Members
QVT ASSOCIATES GP LLCQVT FINANCIAL GP LLCQVT FUND LP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G d273635dsc13g.htm SC 13G 99968
  Complete submission text file 0001193125-11-352289.txt   101609
Mailing Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036
Business Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036 212-705-8800
QVT Financial LP (Filed by) CIK: 0001290162 (see all company filings)

IRS No.: 113694008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Subject) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-83422 | Film No.: 111281208
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1